#avct consolidating at a little lower than I would have hoped but then again, the SP does have a tendency to disappoint 😉

#AVCT RNS is ooozing with confidence. You can’t make deals like that without giving prior reassurances that it can be met. 🫶🏻

If you are confident of near term catalysts to send the SP significantly north…. Defer bond payments to aid cash flow and reduce dilution upon payback to protect share holders. Finally we have financially astute people leading #avct forward alongside the incredible science. 🌟

I think this week we see a strong Mon & Tues hitting 68p+ … perhaps mid 70’s. Consolidation end of the week. imo news will have spread to those less connected to #avct & the weekend to research & inform will have opened new investors eyes. 👀 Exciting times for holders cont

The new #avct website oozes class. Very clear, concise & considered. The SP continues to consolidate…. Which is frustrating mainly because I told the wife I was done buying for a while…. 😳

It’s nice to see some of the various shares doing well…. But I’d be lying if I said I wasn’t jealous whilst waiting patiently for #avct to have a turn! 😂 💯 % belief it will soon 🥂

A huge October on the way. #avct on the cusp of that hugely anticipated commercial deal which almost certainly see’s <£1 as a distant memory. #Faridox

Asked Grok to summarise the relevance of the WHO assigning Faridoxorubicin. #avct CC is doing a truly excellent job. Watch investors take up positions here this week as news spreads. She couldn’t have been much clearer. 🎯

I can’t be the only one that is secretly desperate to ask #avct if this is a letter or a number….. I’m certain it’s a number, but when pronounced like ‘oh’ (the letter) it always raises an eyebrow 🤨😂 Semantics…. I know. But I just needed to get that Q off my chest 😅

Lovely way to finish a Friday…. Although this really hasn’t even got going yet. Hell….. after 5 years and lots of averaging down I’m close to breaking even 😂😭 #avct

‘ #avct has a very bright future….. very bright’ Based on the CEO’s positivity, I think we see the first commercial deal announced before Xmas. IMO it will be this month. Interested to hear others expectations. Feel free to drop in the comments your No1 most likely partner & why

Majority of voted think #avct deal lands this month. No surprises there. Interesting to see a good number still think >Jan26 for first deal, despite the positivity of the board. Can’t wait to see how this plays out. 📈🙏🏻

Lilly’s FAP-RLT screams “de-risked mechanism” to Big Pharma scouts, lighting a fire under Avacta’s door for partnerships & buyouts. It’s like when ADC pioneers like Seagen got a nod from Pfizer before exploding—now everyone’s watching how #avct will deliver the chemo revolution.

4 PR & 5 Minor Responses observed in SGC & STS #avct Conclusion: AVA6k is active in FAPhigh tumors & well tolerated, delivering high concentration of free dox to the TME relative to plasma. Multiple responses. pre|CISION PDC concentrates payload in TME, sparing normal tissue 💥

Tells us more #avct!!!! What is it?!?! Who is it?!?!? WE CANT WAIT UNTIL 25th!!! 🤯😬😍 The re-rate truly has begun.

The market has almost certainly not appreciated this RNS like it should have imo #avct

#avct RNS drops no names. Pfizer’s MMAE or a AZ/Abbvie PBD payload is the winner for me. Lilly have FAP-RLT. Daiichi’s exatecan already in. Merck focused on PD-1 inhibition not cytotoxic payloads. Very interesting to see it unfold. SP reaction found to be lacking… again

AVA6207 #AVCT… Can’t wait for this reveal. Clearly CC was excited by this one…. (Surely no more than ‘The Beast’ though right?!?!?)